Aortic stenosis is a heart valve disease and, in this context, was studied as the outcome in a multi-omics Mendelian randomization framework using mendelian randomization to test causal associations. The analysis linked AS to multiple biological layers, including gut microbiome, blood metabolites, immune cell phenotypes, and circulating inflammatory proteins, suggesting a complex inflammatory-metabolic contribution to…
Immune-related hepatotoxicity, also called ILICI, is an immune-mediated liver injury associated with immune checkpoint inhibitors therapy. It is a clinically significant adverse event in oncology, often managed with steroid therapy and, when steroid-unresponsive, second line treatments. In a multicenter Turkish Oncology Group study, severe hepatic dysfunction was common: grade 3–4 hepatic insufficiency occurred in 24…
TROP-2, also known as trophoblast cell-surface antigen 2, is a membrane-bound cancer antigen and trop 2.2 target that functions primarily as an antibody drug conjugates and imaging/therapy target. It is associated with cancer invasiveness and poorer patient outcomes, and in non-small cell lung cancer (NSCLC) it is being profiled as an ADC target while generalizable…
CCR4 is a C-C chemokine receptor and a therapeutic target for malignancies, functioning as a receptor for the chemokines ccl17 and ccl22. It is targeted by antagonists and has been clinically validated in adult T cell leukemia/lymphoma, cutaneous T cell lymphoma, and other cancers. Structural work has now analyzed CCR4 in the apo state and…
Oocyte aging is a progressive decline in oocyte quality and reproductive potential, driven by age-related stressors that impair cellular homeostasis. Its central mechanisms include oxidative stress, reactive oxygen species-mediated damage, and mitochondrial dysfunction, with the review emphasizing that this decline is progressive with age. The condition is also linked to disruption of redox balance by…
